老虎證券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
STARPHARMA HOLDINGS LTD
0.400
+0.030
8.11%
成交量:
26.26萬
成交額:
10.20萬
市值:
1.67億
市盈率:
-16.70
高:
0.400
開:
0.385
低:
0.375
收:
0.370
52周最高:
0.445
52周最低:
0.082
股本:
4.18億
流通股本:
3.48億
量比:
0.13
換手率:
0.08%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.024
每股收益(LYR):
-0.024
淨資產收益率:
-42.41%
總資產收益率:
-20.06%
市淨率:
8.81
市盈率(LYR):
-16.70
資料載入中...
總覽
公司
新聞資訊
公告
概念
新冠治療股
+0.74%
醫藥生物股
+0.52%
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Radiopharm Theranostics Ltd與Starpharma達成研究與期權協議,共同開發創新放射治療資產
美股速递
·
2025/09/30
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SPL.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.4,"timestamp":1770613920000,"preClose":0.37,"halted":0,"volume":262574,"delay":0,"changeRate":0.08108108108108115,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":418224781,"eps":-0.023946,"marketStatus":"未開盤","change":0.03,"latestTime":"02-09 16:12:00 AEDT","open":0.385,"high":0.4,"low":0.375,"amount":102046,"amplitude":0.067568,"askPrice":0.4,"askSize":121124,"bidPrice":0.39,"bidSize":49299,"shortable":3,"etf":0,"ttmEps":-0.023946,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.37,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":0.13014588090838652,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-20.06%","roe":"-42.41%","lyrEps":-0.023946,"volumeRatio":0.13014588090838652,"shares":418224781,"dividePrice":0,"high":0.4,"amplitude":0.067568,"preClose":0.37,"low":0.375,"week52Low":0.082,"pbRate":"8.81","psRate":"28.60","week52High":0.445,"institutionHeld":0,"latestPrice":0.4,"committee":-0.421451,"eps":-0.023946,"divideRate":0,"volume":262574,"delay":0,"ttmEps":-0.023946,"open":0.385,"prevYearClose":0.36,"prevWeekClose":0.37,"prevMonthClose":0.38,"prevQuarterClose":0.36,"fiveDayClose":0.37,"twentyDayClose":0.38,"sixtyDayClose":0.385},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPL.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1121801444","title":"Radiopharm Theranostics Ltd與Starpharma達成研究與期權協議,共同開發創新放射治療資產","url":"https://stock-news.laohu8.com/highlight/detail?id=1121801444","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121801444?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 18:17","pubTimestamp":1759227434,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics Ltd宣布与Starpharma达成研究与期权协议,双方将携手开发创新的放射治疗资产。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","SPL.AU","BK7067","BK7501","BK7096","RAD.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SPL.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治療股","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":0.007439},{"market":"AU","name":"醫藥生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.00521}]}}